Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Key Takeaways: Copper peptides are naturally occurring compounds that have a major impact on the condition of your skin and hair. They can: To experience the benefits of copper peptides, it is essential to introduce the ingredient into your regular routine. Still, there are certain precautions and considerations to be made when using any topical […]

The post Copper Peptides: A Guide to Benefits for Skin and Hair appeared first on Medical News Bulletin.

KIAWAH ISLAND, S.C. — An anterior keratoplasty technique using a decellularized Descemet’s membrane allograft yielded robust corneal epithelialization in patients with nonhealing ocular surface diseases, according to new research.
BrightMEM from Brightstar Therapeutics is a corneal allograft created from donated human cornea tissue that is designed to be transplanted onto the ocular surface. A study published in Cornea looked at postoperative outcomes of Descemet’s membrane anterior keratoplasty (DMAK) using the allograft.
“We wanted to look specifically at how well it supported healing,

PHOENIX — Results presented at the Arthroscopy Association of North America Annual Meeting showed patellar tendon-lateral trochlear ridge distance may be a reliable measurement for predicting patellofemoral instability.
“[Patellar tendon-lateral trochlear ridge] distance demonstrated higher sensitivity than [tibial tubercle-trochlear groove],” Adam J. Tagliero, MD, associate program director for the Mayo Clinic Sports Medicine Fellowship, said in his presentation. “Surgeons may consider utilizing these measurements in conjunction in the office, since they are all done on axial MRI

The FDA has granted accelerated approval to the first cereblon E3 ligase modulation therapy for patients with multiple myeloma.
Iberdomide (Zenbexus, Bristol Myers Squibb), in combination with daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) and dexamethasone, received approval for adults with multiple myeloma who underwent at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.
“The FDA approval of iberdomide marks the anticipated arrival of a new therapeutic class for relapsed or refractory multiple myeloma and has the potential to make

PHOENIX — While it is uncommon for a patient to lose consciousness in an eye care practice, clinicians and their staff should know the warning signs and how to prevent injury, according to a speaker at Optometry’s Meeting.
Robert Reed Jr., OD, discussed the vasovagal reflex in which the body’s nervous system reacts to a trigger by dropping the heart rate and blood pressure.
{{VIDEO}}
“Their body’s trying to escape from the mental stress of whatever it is they’re encountering,” he told Healio. “They may be aware of it; they may not be aware of it.”
Triggers can include needles, blood, anxiety and

The risk for contracting herpes zoster was elevated in people with atopic dermatitis, independent of comorbidities and conventional systemic treatment, according to a study published in the Journal of the German Society of Dermatology.
The findings showed those with AD were 1.28 times more likely to develop herpes zoster, also known as shingles, than those without AD (95% CI, 1.27-1.29).
“The potential association between AD and herpes zoster has predominantly been discussed in the context of AD treatments. In particular, systemic corticosteroids and immunosuppressants have been associated with

The FDA has approved Tauklarify as a radiodiagnostic agent for adults with cognitive impairment being evaluated via PET scan to identify tau neurofibrillary tangle pathology indicating Alzheimer’s disease, according to a press release.
“As the field continues to advance, clinicians are seeking a more complete understanding of this disease, with tau PET imaging providing information that complements amyloid PET and other diagnostic tools,” Mary Anne Heino, MBA, executive chair and interim CEO, Lantheus, said in the press release.
“Identifying tau neurofibrillary tangle

Patients with immunoglobulin A nephropathy experienced delays between symptom onset to referral, according to study data.
From November to December 2025, James Tumlin, MD, professor of medicine in nephrology at Emory University School of Medicine, and colleagues conducted telephone interviews and an online survey to understand experiences of 126 U.S. adults (median age, 42 years; 34% women; 50% non-Hispanic white) with biopsy-confirmed immunoglobulin A (IgA) nephropathy.
Researchers found 88% of patients reported symptoms before IgA nephropathy diagnosis, including fatigue (75%), hematuria

Problematic social media use may lead to stronger ADHD symptoms and worse cognitive performance among adolescents, according to two studies from the Adolescent Brain Cognitive Development Study cohort.
“A teen who can’t stop using social media despite trying, or whose social media use is interfering with sleep, school, family relationships or daily functioning, may be at greater risk than someone who simply spends a lot of time online,” Jason M. Nagata, MD, MSc, associate professor of pediatrics in the division of adolescent and young adult medicine at University of California, San Francisco,

Eli Lilly and Co. has filed lawsuits against six companies that it claims are selling counterfeit, unapproved versions of its investigational diabetes and obesity drug, retatrutide, according to a press release.
Eli Lilly stated in the release it chose to file lawsuits against six entities selling illegal versions of the glucose-dependent insulinotropic polypeptide (GIP)/GLP-1/glucagon triple agonist, saying that those companies “falsely claim their drugs are for ‘research-use only’ when they are intended for human use.”
The lawsuits were filed against Aesthetic Envy Cosmetic Centers; Astra;